Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanno Ehlken

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Viszeralmedizin|October 16, 2015
How Should Cancer Surveillance in Primary Sclerosing Cholangitis Be Performed?Hanno Ehlken, Christoph Schramm
Journal of Hepatology|January 18, 2014
PSC: Novel disease associations providing pathogenetic clues?Hanno Ehlken, Christoph Schramm
Digestive Diseases (Basel, Switzerland)|June 26, 2013
Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnosticsHanno Ehlken, Christoph Schramm
Current Opinion in Gastroenterology|February 2, 2017
Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: diagnosis and surveillanceHanno Ehlken, Roman Zenouzi, Christoph Schramm
Deutsche Medizinische Wochenschrift (1946)|March 3, 2020
[Diagnostics and Treatment of indeterminate Biliary Stenoses]Jenny Krause, Hanno Ehlken, Christoph Schramm
International Journal of Cancer|November 26, 2003
Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cellsHanno Ehlken, Dirk Schadendorf, Stefan Eichmüller
Gastroenterology|June 29, 2014
Transient elastography in primary sclerosing cholangitis-the value as a prognostic factor and limitationsHanno Ehlken, Ansgar W Lohse, Christoph Schramm
Zentralblatt Fur Chirurgie|June 15, 2022
[Endoscopic Resection for GEP-NET]Hanno Ehlken, Fadi Younis, Stefan Wolter, et al.
Gastrointestinal Endoscopy|April 19, 2020
Waiting times for endotherapy of early malignancy: No problem?Hanno Ehlken, Guido Schachschal, Oliver Mann, et al.
Plos One|October 25, 2011
Hepatocyte IKK2 protects Mdr2-/- mice from chronic liver failureHanno Ehlken, Vangelis Kondylis, Jan Heinrichsdorff, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Viszeralmedizin|October 16, 2015
How Should Cancer Surveillance in Primary Sclerosing Cholangitis Be Performed?Hanno Ehlken, Christoph Schramm
Journal of Hepatology|January 18, 2014
PSC: Novel disease associations providing pathogenetic clues?Hanno Ehlken, Christoph Schramm
Digestive Diseases (Basel, Switzerland)|June 26, 2013
Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnosticsHanno Ehlken, Christoph Schramm
Current Opinion in Gastroenterology|February 2, 2017
Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: diagnosis and surveillanceHanno Ehlken, Roman Zenouzi, Christoph Schramm
Deutsche Medizinische Wochenschrift (1946)|March 3, 2020
[Diagnostics and Treatment of indeterminate Biliary Stenoses]Jenny Krause, Hanno Ehlken, Christoph Schramm
International Journal of Cancer|November 26, 2003
Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cellsHanno Ehlken, Dirk Schadendorf, Stefan Eichmüller
Gastroenterology|June 29, 2014
Transient elastography in primary sclerosing cholangitis-the value as a prognostic factor and limitationsHanno Ehlken, Ansgar W Lohse, Christoph Schramm
Zentralblatt Fur Chirurgie|June 15, 2022
[Endoscopic Resection for GEP-NET]Hanno Ehlken, Fadi Younis, Stefan Wolter, et al.
Gastrointestinal Endoscopy|April 19, 2020
Waiting times for endotherapy of early malignancy: No problem?Hanno Ehlken, Guido Schachschal, Oliver Mann, et al.
Plos One|October 25, 2011
Hepatocyte IKK2 protects Mdr2-/- mice from chronic liver failureHanno Ehlken, Vangelis Kondylis, Jan Heinrichsdorff, et al.
Pageof 4